| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/29/2007 | EP1826207A1 Acid salt of benzimidazole derivative and crystal thereof |
| 08/29/2007 | EP1825854A1 MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR |
| 08/29/2007 | EP1824564A2 Method for treating glioma |
| 08/29/2007 | EP1824481A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 08/29/2007 | EP1824472A1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 08/29/2007 | EP1604673B1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 08/29/2007 | EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1423126B1 Treatment of hyperproliferative conditions of body surfaces |
| 08/29/2007 | EP1412368B1 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1337522B1 farnesyl protein transferase inhibitors |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1259120B1 Method for isolating collagen from marine sponge and producing nanoparticulate collagen, and the use thereof |
| 08/29/2007 | EP1239814B1 Use of the residues from wine production |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1140078B1 Benzimidazole vascular damaging agents |
| 08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
| 08/29/2007 | EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker |
| 08/29/2007 | CN101027069A 神经酰胺酶抑制剂 Ceramidase inhibitor |
| 08/29/2007 | CN101027050A Oral pharmaceutical for dry skin prevention or remedy |
| 08/29/2007 | CN101024831A A tumor necrosis factor related ligand |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101023968A Coenzyme composition preparing method |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN101023757A 人参面粉 Ginseng flour |
| 08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/29/2007 | CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands |
| 08/29/2007 | CN100333797C Novel use of tumor treating of recombinant adenoviral p53 products |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333790C The pharmaceutical applications for combination of drugs with interleukin-2 |
| 08/29/2007 | CN100333778C Chinese medicine for treating cancer |
| 08/29/2007 | CN100333762C Externally used medicine for curing acute or chronic soft tissue injury and process for preparing the same |
| 08/29/2007 | CN100333745C Preparation of Chinese herbal medicine for fight aganist senium |
| 08/29/2007 | CN100333733C Horn removing ointment for cow |
| 08/29/2007 | CN100333715C Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 08/29/2007 | CN100333709C Antioxidant, skin preparation for external use, cosmetic and food |
| 08/29/2007 | CN100333655C Method for preparing milk contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 08/29/2007 | CN100333654C Method for preparing soymilk contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 08/29/2007 | CN100333649C Method for preparing sour milk contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 08/29/2007 | CN100333648C Method for preparing sour soymilk contg. micron ginseng, tortoise, pollen and pearl for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 08/28/2007 | US7262317 Elastase inhibitor; respiratory system disorders; hypotensive agents; administering by injection |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 08/28/2007 | US7262202 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe. |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | US7262186 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl0-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide |
| 08/28/2007 | US7262185 For therapy and prophylaxis of infectious diseases of HIV, in particular, AIDS and is also suitable for oral administration |
| 08/28/2007 | US7262173 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262005 Methods of protein destabilization and uses thereof |
| 08/28/2007 | US7261909 Producing vegetation water from olives; adding acid; incubating the acidified vegetation water for a period of at least two months, until at least 75% of oleoeuropein has been converted to hydroxytyrosol |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | US7261889 Local anesthetic methods and kits |
| 08/28/2007 | CA2504078C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/28/2007 | CA2485337C Analgesic composition and method |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA2294515C Eprosartan monohydrate |
| 08/28/2007 | CA2293338C Isomer enriched conjugated linoleic acid compositions |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/23/2007 | WO2007094391A1 Method for suppressing gene expression utilizing interdomain interaction |
| 08/23/2007 | WO2007094385A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007094312A1 Agent for promoting vitamin c transporter production |
| 08/23/2007 | WO2007094200A1 Skin-whitening cosmetic |
| 08/23/2007 | WO2007094193A1 Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food |
| 08/23/2007 | WO2007093824A1 Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 08/23/2007 | WO2007093611A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | WO2006093276A8 Pluripotent stem cell derived from cardiac tissue |
| 08/23/2007 | US20070197821 Process for the preparation of high purity perindopril |
| 08/23/2007 | US20070197793 Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| 08/23/2007 | US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070197654 Combination of a cb1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease |
| 08/23/2007 | US20070197611 Fermentative preparation process for and crystal forms of cytostatics |
| 08/23/2007 | US20070197602 Combined pharmaceutical composition |
| 08/23/2007 | US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197561 Inhibitors of nucleoside metabolism |
| 08/23/2007 | US20070197560 cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197543 Use of derivatives of 2, 5-dihydroxyb enzene-sulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile dysfunction |
| 08/23/2007 | US20070197527 Bicyclic heteroaromatic compounds |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197503 Solutions containing epinastin |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197466 Synthetic membrane anchors |
| 08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
| 08/23/2007 | US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |